In vivo, SOX17 overexpression, which leads to upregulation of Nestin and downregulation of p16INK4a in lungs of PAH rat models, significantly reduced PAEC senescence, attenuated pulmonary vascular remodeling, and alleviated PAH severity. This evidence concerns the gene CDKN2A and pulmonary arterial hypertension.